Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats

This study investigates the inhibitory effect of astaxanthin (AST) on testosterone-induced benign prostatic hyperplasia (BPH) in rats. Except for the sham operation, BPH model rats were randomly assigned to five groups: the BPH model control rats, AST-treated BPH model rats (20 mg/kg, 40 mg/kg, and...

Full description

Bibliographic Details
Main Authors: Liping Wang, Yiwen Hou, Rong Wang, Qi Pan, Debao Li, Han Yan, Zuyue Sun
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/19/12/652
_version_ 1797502846457872384
author Liping Wang
Yiwen Hou
Rong Wang
Qi Pan
Debao Li
Han Yan
Zuyue Sun
author_facet Liping Wang
Yiwen Hou
Rong Wang
Qi Pan
Debao Li
Han Yan
Zuyue Sun
author_sort Liping Wang
collection DOAJ
description This study investigates the inhibitory effect of astaxanthin (AST) on testosterone-induced benign prostatic hyperplasia (BPH) in rats. Except for the sham operation, BPH model rats were randomly assigned to five groups: the BPH model control rats, AST-treated BPH model rats (20 mg/kg, 40 mg/kg, and 80 mg/kg), and epristeride (EPR)-treated BPH model rats. After treatment, as compared with the BPH model control rats, the prostate and ventral prostate weights of the AST-treated rats decreased, while there was a marked decline in the 80 mg/kg AST-treated rats. The same effect was also observed in the prostate index and ventral prostate index. The proliferation characteristics of epithelia observed in the BPH model control group were gradually alleviated in the AST-treated rats. As compared with the BPH model control rats, lower epithelial thicknesses of prostates and fewer secretory granules in epithelia were observed in the AST-treated rats. The superoxide dismutase (SOD) activity of prostates increased in all the AST-treated rats with a significant increase in the 40 mg/kg and 80 mg/kg AST-treated rats. The testosterone (T) and dihydrotestosterone (DHT) levels of prostates in the AST-treated groups were lower than those in the BPH model control group, and a significant decline was found in the T level of prostates in the 40 g/kg and 80 mg/kg AST-treated rats and the DHT level of prostates in the 40 mg/kg AST-treated rats. These results indicate that AST might have an inhibitory effect on T-induced BPH in rats, possibly due to SOD activity regulation and T and DHT levels.
first_indexed 2024-03-10T03:41:59Z
format Article
id doaj.art-62beceb9ba25428e8f4f3e0f87d616a1
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T03:41:59Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-62beceb9ba25428e8f4f3e0f87d616a12023-11-23T09:17:45ZengMDPI AGMarine Drugs1660-33972021-11-01191265210.3390/md19120652Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in RatsLiping Wang0Yiwen Hou1Rong Wang2Qi Pan3Debao Li4Han Yan5Zuyue Sun6NHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaNHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaNHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaNHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaNHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaNHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaNHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai 200032, ChinaThis study investigates the inhibitory effect of astaxanthin (AST) on testosterone-induced benign prostatic hyperplasia (BPH) in rats. Except for the sham operation, BPH model rats were randomly assigned to five groups: the BPH model control rats, AST-treated BPH model rats (20 mg/kg, 40 mg/kg, and 80 mg/kg), and epristeride (EPR)-treated BPH model rats. After treatment, as compared with the BPH model control rats, the prostate and ventral prostate weights of the AST-treated rats decreased, while there was a marked decline in the 80 mg/kg AST-treated rats. The same effect was also observed in the prostate index and ventral prostate index. The proliferation characteristics of epithelia observed in the BPH model control group were gradually alleviated in the AST-treated rats. As compared with the BPH model control rats, lower epithelial thicknesses of prostates and fewer secretory granules in epithelia were observed in the AST-treated rats. The superoxide dismutase (SOD) activity of prostates increased in all the AST-treated rats with a significant increase in the 40 mg/kg and 80 mg/kg AST-treated rats. The testosterone (T) and dihydrotestosterone (DHT) levels of prostates in the AST-treated groups were lower than those in the BPH model control group, and a significant decline was found in the T level of prostates in the 40 g/kg and 80 mg/kg AST-treated rats and the DHT level of prostates in the 40 mg/kg AST-treated rats. These results indicate that AST might have an inhibitory effect on T-induced BPH in rats, possibly due to SOD activity regulation and T and DHT levels.https://www.mdpi.com/1660-3397/19/12/652astaxanthinbenign prostatic hyperplasiapharmacodynamicsSOD activity
spellingShingle Liping Wang
Yiwen Hou
Rong Wang
Qi Pan
Debao Li
Han Yan
Zuyue Sun
Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
Marine Drugs
astaxanthin
benign prostatic hyperplasia
pharmacodynamics
SOD activity
title Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
title_full Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
title_fullStr Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
title_full_unstemmed Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
title_short Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
title_sort inhibitory effect of astaxanthin on testosterone induced benign prostatic hyperplasia in rats
topic astaxanthin
benign prostatic hyperplasia
pharmacodynamics
SOD activity
url https://www.mdpi.com/1660-3397/19/12/652
work_keys_str_mv AT lipingwang inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats
AT yiwenhou inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats
AT rongwang inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats
AT qipan inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats
AT debaoli inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats
AT hanyan inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats
AT zuyuesun inhibitoryeffectofastaxanthinontestosteroneinducedbenignprostatichyperplasiainrats